EVOKE PHARMA INC (EVOK) Stock Analyst Ratings
USA - NASDAQ:EVOK - US30049G3020 - Common Stock
4.5711 USD
-0.04 (-0.84%)
ChartMill assigns a Buy % Consensus number of 83% to EVOK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.36. This target is 301.65% above the current price.
EVOK was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about EVOK.
In the previous month the buy percentage consensus was at a similar level.
EVOK was analyzed by 7 analysts. More opinions would make the average more meaningful.